NCT00063895 2013-01-09Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and NeckNational Cancer Institute (NCI)Phase 1/2 Completed80 enrolled